New AI-Powered heart monitor put to the test

NCT ID NCT06713226

Terminated Diagnosis Sponsor: VUNO Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study was designed to test a new portable ECG recorder called Hativ P30, which uses artificial intelligence to analyze heart rhythms. Researchers planned to compare its readings to a standard 12-lead ECG in adults, including those with and without arrhythmias. However, the study was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hativ P30 electrocardiogram recorder device

What this could lead to

If successful, this device could offer a more portable and AI-assisted way to record heart rhythms, potentially making arrhythmia detection easier outside of clinics.

What could go wrong

This study was withdrawn before enrolling anyone, so no data was collected. The device's accuracy and safety compared to standard ECGs remain unproven.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation atrial flutter cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIA